Journal of psychiatric research · 2025
Determinants of real-world functioning in first-episode psychosis patients receiving 4 weeks of amisulpride treatment: findings from the multinational OPTiMiSE study.
СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
García-Álvarez Leticia, García-Portilla González María Paz, Winter Inge, Rodriguez-Jimenez Roberto, Sáiz Pilar Alejandra, Bobes Julio
Аннотация
INTRODUCTION: Identifying factors that promote real-world functioning in patients with first-episode psychosis (FEP) may guide the development of effective interventions.
OBJECTIVE: To determine factors associated with real-world functioning in FEP patients after 4 weeks of amisulpride treatment.
METHODS: A total of 354 FEP patients were included. Baseline assessments covered socio-demographic and clinical data, the Positive and Negative Syndrome Scale (PANSS), and the Calgary Depression Rating Scale. Real-world functioning was assessed at week 4 using the Personal and Social Performance scale.
RESULTS: After 4 weeks, 69.2 % of patients were in remission, while 27.7 % showed good real-world functioning. More years of education (estimator = 0.54) and lower baseline levels of depressive (estimator = -0.37) and amotivational symptoms (estimator = -0.79) were protective factors for general functioning. Non-remission at week 4 (estimator = 15.33) significantly increased the risk of poor functioning. Amotivation and non-remission were also linked to worse outcomes in work and social relationships areas. Regarding self-care, more years of education (estimator = -0.04), fewer depressive symptoms (estimator = 0.03), and not using cannabis (estimator = -0.19) were protective. For aggressive behavior functioning, higher levels of diminished expression (estimator = -0.03), lower levels of depressive symptoms (estimator = 0.02) and positive symptoms (estimator = 0.02), as well as remission at week 4 (estimator = -0.37), were protective.
CONCLUSION: Negative symptoms, specifically amotivation and diminished expression, play a key role in real-world functioning. Amotivation impacts general and domain-specific functioning, while positive symptoms and diminished expression mainly affect aggressive behaviors area.
OBJECTIVE: To determine factors associated with real-world functioning in FEP patients after 4 weeks of amisulpride treatment.
METHODS: A total of 354 FEP patients were included. Baseline assessments covered socio-demographic and clinical data, the Positive and Negative Syndrome Scale (PANSS), and the Calgary Depression Rating Scale. Real-world functioning was assessed at week 4 using the Personal and Social Performance scale.
RESULTS: After 4 weeks, 69.2 % of patients were in remission, while 27.7 % showed good real-world functioning. More years of education (estimator = 0.54) and lower baseline levels of depressive (estimator = -0.37) and amotivational symptoms (estimator = -0.79) were protective factors for general functioning. Non-remission at week 4 (estimator = 15.33) significantly increased the risk of poor functioning. Amotivation and non-remission were also linked to worse outcomes in work and social relationships areas. Regarding self-care, more years of education (estimator = -0.04), fewer depressive symptoms (estimator = 0.03), and not using cannabis (estimator = -0.19) were protective. For aggressive behavior functioning, higher levels of diminished expression (estimator = -0.03), lower levels of depressive symptoms (estimator = 0.02) and positive symptoms (estimator = 0.02), as well as remission at week 4 (estimator = -0.37), were protective.
CONCLUSION: Negative symptoms, specifically amotivation and diminished expression, play a key role in real-world functioning. Amotivation impacts general and domain-specific functioning, while positive symptoms and diminished expression mainly affect aggressive behaviors area.